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Introduction: A clinical suspicion of infection is mandatory for diagnosing sepsis in patients with a systemic
inflammatory response syndrome. Yet, the accuracy of categorizing critically ill patients presenting to the intensive
care unit (ICU) as being infected or not is unknown. We therefore assessed the likelihood of infection in patients
who were treated for sepsis upon admission to the ICU, and quantified the association between plausibility of
infection and mortality.
Methods: We studied a cohort of critically ill patients admitted with clinically suspected sepsis to two tertiary ICUs
in the Netherlands between January 2011 and December 2013. The likelihood of infection was categorized as none,
possible, probable or definite by post-hoc assessment. We used multivariable competing risks survival analyses to
determine the association of the plausibility of infection with mortality.
Results: Among 2579 patients treated for sepsis, 13% had a post-hoc infection likelihood of “none”, and an additional
30% of only “possible”. These percentages were largely similar for different suspected sites of infection. In crude
analyses, the likelihood of infection was associated with increased length of stay and complications. In multivariable
analysis, patients with an unlikely infection had a higher mortality rate compared to patients with a definite infection
(subdistribution hazard ratio 1.23; 95% confidence interval 1.03-1.49).
Conclusions: This study is the first prospective analysis to show that the clinical diagnosis of sepsis upon ICU
admission corresponds poorly with the presence of infection on post-hoc assessment. A higher likelihood of infection
does not adversely influence outcome in this population.
Trial registration: ClinicalTrials.gov NCT01905033. Registered 11 July 2013.Introduction
Sepsis is a syndrome that arises when the body’s re-
sponse to a severe infection injures its own tissues. In
1992 an international consensus panel proposed a clin-
ical definition for sepsis, making use of the concept of a
“systemic inflammatory response syndrome” (SIRS),
involving alterations in body temperature, heart rate,
respiration rate, and leukocyte counts [1]. The panel* Correspondence: p.m.c.kleinklouwenberg@umcutrecht.nl
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further introduced the terms severe sepsis to describe
cases when sepsis is complicated by acute organ dys-
function and septic shock as severe sepsis complicated
by hypotension refractory to fluid resuscitation. These
definitions, generally referred to as the “Bone criteria”,
have been used as inclusion criteria in many clinical sep-
sis trials, and until today have remained largely un-
changed [2].
Although the clinical suspicion of infection is a crucial
factor in making a sepsis diagnosis, little is known about
the accuracy of this diagnosis in the context of critically
ill patients who present to the ICU with signs and symp-
toms of a “sepsis syndrome”. We hypothesized that ins This article is distributed under the terms of the Creative Commons Attribution
ons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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not based on strict diagnostic criteria for infection and
that as a consequence the occurrence of sepsis on the
ICU might be overestimated. Quantification of this
discordance is helpful for estimating incidence rates in
epidemiological studies and the possible reduction of
antibiotic use.
To address this hypothesis we assessed the concord-
ance between the prospective clinical sepsis diagnosis
made by bedside physicians and the post-hoc diagnosis
of infection made by clinical researchers using strict
criteria. In addition, we assessed the association of the
likelihood of infection with outcome.
Methods
Study design and population
This cohort study was incorporated in the Molecular
Diagnosis and Risk Stratification of Sepsis (MARS) pro-
ject in the mixed ICUs of two tertiary referral centers in
the Netherlands [3, 4]. The local ethical committee
approved the study with opt-out consent (Medisch
Ethische Toetsingscommissie UMC Utrecht; number
10-056C; approval 16 June 2010). Participants were
notified of the study in writing by a brochure pro-
vided at ICU admission with an attached opt-out card
that could be completed by the patient or by his or
her legal representative in case of unwillingness to
participate. For the current study, we analyzed all first
admissions of adult patients with a sepsis diagnosis who
were admitted between January 2011 and December 2013,
with an expected stay of >24 hours.
Data collection and definitions
Dedicated and trained observers prospectively collected
relevant data from all patients. An infectious event was
prospectively recorded when systemic antibiotics were
started for therapeutic reasons by the attending phys-
ician, as described previously [3]. For this study, we in-
cluded infections that were diagnosed before ICU
admission or until 48 hours afterwards. Patients who
were initially not suspected of having an infection at ad-
mission (i.e., those not receiving therapeutic antibiotics
at ICU admission), but in whom therapeutic antibiotics
were started later than 2 days after admittance because
the positive cultures and the continuous presence of
clinical symptoms from the time of admission onwards
suggested an infection in retrospect, were also included
in this study. The clinical research team in these cases
dated the sepsis event to the start of clinical symptoms.
We performed a sensitivity analysis in which we ex-
cluded infections starting more than 48 hours before
admission, because we anticipated that the diagnostic
likelihood of these infections differed from those
starting directly prior to admission. Of note, patientsreceiving (only) prophylactic antibiotics were not as-
sumed to have sepsis.
The plausibility of infection (none, possible, prob-
able, definite) was determined post hoc, based on all
available clinical, microbiological, and radiological
evidence and according to the Centers for Disease
Control and Prevention (CDC) and the International
Sepsis Forum (ISF) criteria [5, 6]. This post-hoc
assessment was used as the “gold standard” for infec-
tion in our study. In short, independent observers
discussed all patients with (senior) critical care
physicians and infection specialists in daily multidis-
ciplinary meetings, and performed a confirmatory re-
view of the medical record at the time of ICU
discharge or death, including any postmortem find-
ings. All diagnoses were therefore made after con-
sensus and continuous data integrity checks. The
precise definitions used to diagnose infection in the
present study are described in a previous publication
by our consortium [3].
SIRS criteria were defined as: temperature <36.0 °C or
>38.0 °C during at least 2 hours and 1 hour, respectively;
white blood cell count <4 × 109/l or >12 × 109/l, or >10 %
immature (band) forms; heart rate >90/minute during at
least 1 hour; respiratory rate >20/minute during at least 1
hour, partial pressure of carbon dioxide <32 mmHg, or
mechanical ventilation [1, 7]. Sepsis was defined as at least
two SIRS criteria plus the clinical suspicion of infection by
senior clinicians; we chose this “conventional” sepsis def-
inition making use of the SIRS criteria to allow for inter-
pretation in the context of the many previous sepsis trials
using these criteria [2]. In addition, patients with “do not
resuscitate” orders with clinical suspicion of sepsis, but
without antibiotics, were classified as having sepsis. Cri-
teria for organ failure included the following signs of
organ hypoperfusion or dysfunction: areas of mottled skin;
capillary refilling requiring 3 seconds or longer; urine out-
put <0.5 ml/kg for at least 6 hours, elevated creatinine, or
renal replacement therapy [8]; lactate >2 mmol/l; abrupt
change in mental status; abnormal electroencephalo-
graphic findings; platelet count <100,000 platelets/ml or
disseminated intravascular coagulation; acute respiratory
distress syndrome; and cardiac dysfunction, as defined
by echocardiography or direct measurement of the
cardiac index [9]. Shock was defined as the presence
of severe sepsis plus the use of noradrenaline at a
dose of >0.1 μg/kg/minute during at least 50 % of the
day. ICU-related complications such as ICU-acquired
infections, acute kidney injury, and adult respiratory
distress syndrome that were present at or occurred
during ICU admission were prospectively registered
[10, 11]. For ICU-acquired infections, only infections
that started >48 hours after admission with a probability
of at least “possible” were included.
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locally adapted protocols based on the Surviving Sepsis
Campaign guidelines [12].
Statistical analyses
All results are presented as median and interquartile
range (IQR) or number and percentage, as appropriate.
Continuous nonparametric data were analyzed using a
Kruskal–Wallis test and categorical data were analyzed
using the chi-squared test. The Cochran–Armitage test
for trend and the Gray’s test for equality of cumulative
incidence functions were used.
We assessed the effect of infection plausibility on ICU
mortality using a competing risks survival analysis to ac-
count for informative censoring [13]. A competing risks
analysis provides two measures of association: the cause-
specific hazard ratio (CSHR), which estimates the direct
effects of infection on outcome (both ICU discharge and
death); and the subdistribution hazard ratio (SHR),
which is a summary measure of all separate cause-
specific hazards and can be used to calculate the cumu-
lative incidence of the outcome of interest (i.e., death in
this study) [14]. The plausibility of infection was in-
cluded as a dichotomous variable (none/possible vs.
probable/definite). We adjusted for confounders that
were chosen a priori based on their expected associations
with infection and mortality after careful consideration of
the literature and based on clinical expertise. These in-
cluded age, gender, cardiovascular disease, immunocom-
promised state, malignancy, diabetes mellitus, respiratory
insufficiency, renal insufficiency, recent surgery, sepsis se-
verity, site of infection, and Acute Physiology and Chronic
Health Evaluation (APACHE) IV score. p <0.05 was con-
sidered statistically significant. All analyses were per-
formed using SAS 9.2 (SAS Institute, Cary, NC, USA) and
R version 3.10 [15].
Results
Demographics
Over the 3-year observation period we studied 6944 pa-
tients during 7347 hospitalizations contributing a total
of 8259 ICU episodes, of which 912 ICU readmissions
were excluded from analysis. At admission, 2738 patients
(37 %) received therapeutic antimicrobials for a clinical
suspicion of infection, of whom 2579 (94 %) had at least
two SIRS criteria and were thus diagnosed with sepsis.
Table 1 presents the main characteristics of patients pre-
senting to the ICU with a clinical diagnosis of sepsis.
C-reactive protein and core temperature increased
significantly with increasing likelihoods of infection,
in contrast to leukocyte counts. The most frequent
suspected primary sources of sepsis in the retrospective
review of cases were pulmonary (community-acquired
and hospital-acquired pneumonia, n = 1292), abdominal(peritonitis, n = 414), bloodstream (endocarditis, primary
bloodstream, and catheter-related bloodstream, n = 230),
urinary tract (n = 162), and skin or soft tissue (n = 118) in-
fections. The remaining 363 patients had infections at
other sites.
Accuracy of infection diagnosis
Of all patients treated for sepsis, 13 % had an infection
likelihood of “none” upon post-hoc analysis (Table 1).
An additional 30 % had an infection likelihood of pos-
sible, whereas slightly more than half scored a higher in-
fection likelihood (25 % probable and 33 % definite).
Limiting the analysis to infections that were diagnosed
within 48 hours before admission resulted in a similar
distribution (n = 2117): 15 %, 32 %, 25 %, and 28 % were
classed as none, possible, probable, and definite infec-
tions, respectively. Figure 1 shows the plausibility of in-
fection after post-hoc analysis for the whole cohort, and
stratified by sepsis severity. Although the accuracy of the
infection diagnosis according to the post-hoc adjudica-
tion increased with greater sepsis severity, there was still
considerable misclassification in patients with organ fail-
ure (40 % of patients classified as none or possible) or
shock (34 %). Figure 2 shows the plausibility of infection
after post-hoc analysis for the five most prevalent
sources of infection. The proportion of definite and
probable infections was largely similar in patients with
different sources of infection, although the percentage of
definite cases in pneumonia patients was significantly
lower compared with the whole cohort (16 % vs. 33 %,
p <0.001). Furthermore, there were no likelihoods of
“none” in the cases with skin or soft tissue infection.
Additional file 1 shows all (both sepsis and nonsepsis)
diagnoses that were registered in patients by category
of infection likelihood.
Outcomes
Figure 3 shows various patient outcomes in the whole
population, and stratified by infection likelihood and the
most prevalent presumed sources of infection. The
plausibility of infection was not associated with mortality
either in the entire patient population admitted with a
sepsis diagnosis (21 %, 18 %, 20 %, and 20 % mortality in
patients with infection likelihoods of none, possible,
probable, and definite, respectively) or in any of the
main subgroups of presumed infection sites except for
the lungs. Figure 4 displays the cumulative incidence
functions of mortality for the none–possible vs. prob-
able–definite classes of infection plausibility. The confi-
dence intervals for all four categories overlap, meaning
that in this crude survival analysis plausibility of infection
was also not associated with mortality (p = 0.73; crude
SHR 1.05; 95 % confidence interval (CI) 0.88–1.25). In the
multivariable analysis, however, a higher plausibility of
Table 1 Baseline characteristics of patients admitted with presumed sepsis
All Post-hoc plausibility of infection
None Possible Probable Definite p value
Number 2579 (100 %) 332 (13 %) 771 (30 %) 633 (25 %) 843 (33 %) n/a
Demographics
Age (years) 62 (49, 71) 62 (48, 72) 62 (51, 71) 62 (49, 71) 62 (49, 71) 0.73
Gender, male 1540 (60 %) 181 (55 %) 493 (64 %) 365 (58 %) 501 (59 %) 0.04
Race, Caucasian 2257 (88 %) 278 (84 %) 688 (89 %) 552 (87 %) 739 (88 %) 0.09
Body mass index >30 kg/m2 479 (19 %) 53 (16 %) 166 (22 %) 93 (15 %) 167 (20 %) 0.004
Comorbidities
Charlson comorbidity index 3.5 (0, 9.1) 1.5 (0, 8.1) 2.5 (0.0, 9.4) 4.6 (0.0, 9.4) 4.6 (0.0, 9.7) 0.02
Cardiovascular diseasea 605 (23 %) 81 (24 %) 204 (26 %) 142 (22 %) 178 (21 %) 0.07
Respiratory insufficiencyb 432 (17 %) 50 (15 %) 141 (18 %) 120 (19 %) 121 (14 %) 0.05
Renal insufficiencyc 329 (13 %) 31 (9 %) 98 (13 %) 70 (11 %) 130 (15 %) 0.02
Malignancyd 239 (9 %) 20 (6 %) 61 (8 %) 68 (11 %) 90 (11 %) 0.02
Immunocompromised statee 628 (24 %) 68 (20 %) 159 (21 %) 173 (27 %) 228 (27 %) 0.002
Diabetes mellitus 486 (19 %) 63 (19 %) 143 (19 %) 119 (19 %) 161 (19 %) 0.99
Admission characteristics
Surgical admission 661 (26 %) 88 (27 %) 186 (24 %) 122 (19 %) 265 (31 %) <0.001
APACHE IV score 77 (66, 100) 74 (58, 101) 75 (58, 96) 79 (61, 100) 79 (60, 101) 0.08
Core temperature 37.8 (37.0, 38.6) 37.6 (36.9, 38.4) 37.7 (37.0, 38.5) 37.9 (37.1, 38.6) 37.9 (37.1, 38.7) <0.001
White blood cell count 14.2 (9.6, 19.8) 13.5 (9.9, 18.8) 14.6 (10.4, 19.0) 14.2 (9.6, 20.1) 14.5 (8.5, 20.5) 0.88
C-reactive protein 114 (35, 229) 36 (8, 102) 86 (19, 181) 125 (47, 234) 170 (78, 270) <0.001
Creatinine 104 (70, 171) 101 (68, 167) 100 (69, 157) 94 (65, 158) 118 (75, 198) <0.001
Sepsis severity at admission <0.001
Sepsis 1076 (42 %) 175 (53 %) 380 (49 %) 238 (38 %) 283 (34 %)
Severe sepsis 727 (28 %) 70 (21 %) 224 (29 %) 198 (31 %) 235 (28 %)
Septic shock 776 (30 %) 87 (26 %) 167 (22 %) 197 (31 %) 325 (39 %)
Organ failure at admissionf
Central nervous system 0.0 (0.0, 1.0) 0.0 (0.0, 1.0) 0.0 (0.0, 1.0) 0.0 (0.0, 1.0) 0.0 (0.0, 1.0) 0.22
Cardiovascular 3.0 (1.0, 4.0) 3.0 (1.0, 4.0) 3.0 (1.0, 4.0) 3.0 (1.0, 4.0) 3.0 (1.0, 4.0) <0.001
Respiratory 2.5 (2.0, 3.0) 3.0 (2.0, 3.0) 3.0 (2.0, 3.0) 3.0 (2.0, 3.0) 2.0 (2.0, 3.0) 0.35
Renal 0.0 (0.0, 2.0) 0.0 (0.0, 1.0) 0.0 (0.0, 1.0) 0.0 (0.0, 1.0) 1.0 (0.0, 3.0) <0.001
Hepatic 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) <0.001
Coagulation 0.0 (0.0, 1.0) 0.0 (0.0, 1.0) 0.0 (0.0, 1.0) 0.0 (0.0, 1.0) 0.0 (0.0, 1.5) <0.001
Total 7.0 (5.0, 10) 7.0 (5.0, 10) 7.0 (4.0, 9.0) 7.0 (5.0, 9.0) 8.0 (5.0, 11) <0.001
Treatment at admission
Mechanical ventilation 2016 (78 %) 261 (79 %) 608 (79 %) 492 (78 %) 655 (78 %) 0.93
Dialysis 263 (10 %) 39 (12 %) 67 (9 %) 54 (9 %) 103 (12 %) 0.037
Data presented as median (interquartile range) or number (%). The four infection plausibility classes were compared using the Kruskal–Wallis test or the
chi-squared test
aCardiovascular disease was defined as cerebrovascular disease or chronic cardiovascular insufficiency (New York Heart Association class 4), chronic congestive
heart failure (ejection fraction <30 %), or peripheral vascular disease (intermittent claudication, patients with percutaneous transluminal angioplasty, or bypass for
arterial insufficiency)
bRespiratory insufficiency was defined as chronic obstructive pulmonary disease or chronic respiratory insufficiency with functional disabilities (chronic mechanical
ventilation, oxygen use at home, or severe pulmonary hypertension)
cRenal insufficiency was defined as chronic renal insufficiency (creatinine >177 μmol/l) or chronic dialysis
dMalignancy included both metastatic and hematologic malignancies
eImmunocompromised state was defined as having acquired immunodeficiency syndrome, the use of corticosteroids in high doses (equivalent to prednisolone of
>75 mg/day for at least 1 week), current use of immunosuppressive drugs, current use of antineoplastic, drugs recent hematologic malignancy, or documented
humoral or cellular deficiency
fBased on the Sequential Organ Failure Assessment scores
APACHE Acute Physiology and Chronic Health Evaluation, n/a not applicable
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Fig. 1 Plausibility of infection stratified by clinical severity upon
presentation in patients with presumed sepsis. Comparison
between the clinical diagnosis of infection at the time of ICU
admission and the actual presence of infection as determined
by post-hoc evaluation
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mortality (SHR 0.81; 95 % CI 0.67–0.97). This means that
patients with a confirmed infection diagnosis actually have
a lower mortality rate than patients with an unconfirmed
infection or an alternative diagnosis. Cause-specific ana-
lysis revealed that this reduction was caused by a direct ef-
fect on death (CSHR 0.73; 95 % CI 0.61–0.89), and not by
the indirect effect on a longer ICU length of stay (CSHR
0.93; 95 % CI 0.85–1.02). In subgroup analyses, the mor-
tality hazard for each hospital was similar (hospital A:
SHR 0.80, 95 % CI 0.62–1.03; hospital B: SHR 0.85, 95 %
CI 0.63–1.13). These estimates were similar when restrict-
ing our analysis to cases with none or definite infections
only (SHR 0.75, 95 % CI 0.55–1.01). Furthermore, theFig. 2 Plausibility of infection in patients with presumed sepsis upon
presentation for the most frequent sites of infection. Distribution of
plausibility of infection for lung infections (community-acquired
pneumonia and hospital-acquired pneumonia), abdominal infections
(primary and secondary peritonitis), bloodstream infections (primary
bloodstream infections, catheter-related bloodstream infections, and
endocarditis), urinary tract infections, and skin/soft tissue infectionsprevalence of the adult respiratory distress syndrome, the
prevalence of acute kidney injury, and the length of stay
significantly increased with greater infection likeli-
hoods (p <0.001), whereas the occurrence of ICU-
acquired infections did not (p = 0.36) (Fig. 3). In the
main subgroups of presumed infection sites, the in-
fection plausibility was not associated with outcome
parameters in this crude analysis, except for pulmon-
ary infections.
Discussion
We determined the accuracy of the infection diagnosis
made by clinicians in the context of presumed sepsis
upon admission to the ICU and found that up to 43 %
of patients treated for sepsis were unlikely to have had
an infection on post-hoc assessment. Although the ac-
curacy of the infection diagnosis increased with increas-
ing severity of disease, a considerable proportion of
patients with severe sepsis and septic shock still had at
most a possible infection. These results show that mak-
ing an accurate infection diagnosis upon ICU admission
in patients with suspected sepsis is difficult in many
cases.
Our study is the first prospective comparison of sepsis
diagnoses made by ICU physicians and post-hoc analyses
of infection likelihoods based on strict diagnostic cri-
teria, revealing that the true incidence of sepsis upon
ICU admission is probably overestimated. Only few pre-
vious studies have specifically investigated the accuracy
of infection diagnoses in patients with suspected sepsis
in the ICU. A French study found that 49 % of patients
were potentially unnecessarily treated for a new infec-
tion on the ICU [16]. This finding was based on the level
of microbiological evidence and not on well-defined
diagnostic criteria, however, making it difficult to appre-
ciate the true percentage of patients without infection in
post-hoc analysis. Another study explored the correl-
ation of clinical certainty at the start of antimicrobial
therapy with the post-hoc presence of infection [17].
The primary aim of this latter investigation focused on
antimicrobial use, namely how often administration of
antimicrobials for suspected infection could be justified
by the presence of infection; a large proportion of pa-
tients treated with empirical antibiotics (58 of the 125;
46 %) actually had no infection according to the infec-
tious diseases specialist in the post-hoc assessment [17].
In crude analysis, the likelihood of infection in patients
treated for suspected sepsis was not associated with
mortality. Since several factors that impact on ICU mor-
tality were unequally distributed between groups, we
performed multivariable survival analysis and found that
a lower likelihood of infection was associated with in-
creased mortality. In other words, patients who were
initially treated for sepsis but had, in retrospect, a
Fig. 3 Patient outcomes for various sites of infection stratified by plausibility of infection. Data are crude associations. The length of ICU stay (LoS)
is shown as median. ICU-acquired infections (ICU-AI) were defined as infections that started >48 hours after admission with a plausibility of infection of
at least possible. Acute kidney injury (AKI) and adult respiratory distress syndrome (ARDS) that were present at or occurred during ICU admission were
taken into account. Whiskers indicate the 95 % CI. p values indicate the results of the Cochran-Armitage chi-square test for trend. Urinary tract and
skin/soft tissue infections are not shown because of relatively small subgroups after stratification
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compared with patients with an infection. This obser-
vation is probably related to variations in underlying
pathology, but may also partly be due to the diagnos-
tic delay that resulted from an incorrect working
diagnosis. Furthermore, these data suggest that infec-
tion does not result in worse outcome compared with
other critical conditions. It is important to note that
the increasing incidences of complications such as
acute kidney injury and adult respiratory distress syn-
drome in cases with higher plausibilities of infection
are markers of a “correct” sepsis diagnosis and should
not be interpreted as causal factors of the lower ad-
justed mortality rates in noninfectious cases.As the discrimination between infectious and non-
infectious causes of critical illness in the ICU using
clinical parameters only has proved challenging, mul-
tiple studies have been performed into the value of
other markers, such as host biomarkers for the diag-
nosis of infection [18, 19]. While some biomarkers,
such as procalcitonin, may aid in limiting the dur-
ation of antibiotic therapy in ICU patients [20], at
present there are no biomarkers that provide suffi-
cient diagnostic accuracy to withhold antibiotics as
initial therapy in ICU patients with suspected infec-
tion [18, 21, 22]. While biomarkers would be valu-
able for diagnosis in reducing antibiotic use in this
patient population, our current study suggests that
Fig. 4 Crude and adjusted cumulative incidence functions of mortality stratified by plausibility of infection. The adjusted curve (right) was plotted
by imputing average values of age, gender, cardiovascular disease, immunocompromised state, malignancy, diabetes mellitus, respiratory
insufficiency, renal insufficiency, recent surgery, sepsis severity, site of infection, and APACHE IV score into the model
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the infection diagnosis itself is less important.
A limitation of this study concerns the inherently
somewhat complex CDC and ISF infection definitions
used for the post-hoc assessment for the presence of in-
fection. We therefore determined the diagnostic agree-
ment among the study team in a separate study, and
concordance was found to be good [3]. In contrast to
this previous study, the current process of prospective
surveillance involved discussions among observers, dis-
cussions with (senior) clinicians in multidisciplinary
meetings attended by critical care physicians and infec-
tion specialists, and continuous checks of data integrity.
All diagnoses were therefore made after consensus. As
such, our post-hoc analyses represent an “ideal” situation
with availability of all diagnostic data collected after the
acute event. Consequently, our study should not be
interpreted as an analysis of the adequacy of clinical ac-
tion in the ICU, but rather as an attempt to assess the
true incidence of infection in patients admitted with sus-
pected sepsis. In this respect it is important to note that
in large surveys the rapid administration of broad-
spectrum antibiotics to patients with clinically diagnosed
septic shock is associated with a time-dependent in-
crease in survival [23, 24], suggesting that the benefit of
early antibiotic treatment in patients with infection is
greater than the potential harm of unnecessary anti-
microbial therapy in those without infection. Notably,
relative to other sources of infection, only few pneumo-
nia cases fulfilled the criteria for definite infection. This
was most probably caused by a relatively strict definition
for pneumonia [3]. Furthermore, any systemic use of
antibiotics before admission may have influenced
culture results obtained in the ICU and therefore also
the recorded likelihood of infection. However, apositive culture was not necessarily needed to diagnose a
probable infection, including for the most commonly
observed community-acquired infection in our study
(pneumonia). For patients with hospital-acquired in-
fections, this issue was deemed less problematic since
blood (and other) cultures were typically collected be-
fore the start of antibiotics. Another limitation in-
volves the fact that this study was performed in two
centers in the Netherlands and may not reflect gen-
eral ICU practice. Lastly, as is true for all observa-
tional studies, we cannot rule out the possibility that
unobserved confounding might have occurred in the
mortality analysis. However, the adjustment methods
used were identical for all subgroups.
Conclusions
This first prospective analysis of the accuracy of the in-
fection diagnosis in patients with suspected sepsis on
ICU admission shows that the clinical diagnosis of sepsis
corresponds poorly with the actual presence of infection,
as defined by CDC/ISF diagnostic criteria. These results
suggest that the true incidence of sepsis may have been
overestimated in many studies. In fact, a substantial por-
tion of patients being enrolled in clinical sepsis trials
may in fact not have probable or definite infection,
which may negatively impact the power of such trials to
show benefit of certain sepsis treatments.
Key messages
 The clinical diagnosis of sepsis on admission
corresponds poorly with the presence of infection
defined by strict diagnostic criteria.
 A higher likelihood of infection does not negatively
impact the mortality of patients treated for sepsis.
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Additional file 1: Is Table S1 presenting diagnoses in patients
admitted with sepsis by infection likelihood. Overview of all (both
sepsis and nonsepsis) diagnoses that were recorded in patients upon
admission by category of infection likelihood. (PDF 144 kb)
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